1. Brooks BR. Amyotrophic lateral sclerosis clinimetric scales: guidelines for administration and scoring. In: Herndon RM, editor. Handbook of clinical neurologic scales. New York: Demos Vermande, 1997: 27–79.
2. Brooks BR, Lewis D, Rawling J, Sanjak M, Belden D, Hakim H, et al. The natural history of ALS. In: Williams AC, editor. Motor neuron disease. London: Chapman and Hall, 1994:131170.
3. Brooks BR, Shodis KA, Lewis DH, Rawling JD, Sanak M, Belden DS, et al. Natural history of amyotrophic lateral sclerosis–quantification of symptoms, signs, strength and function. In: Serratrice G, Munsat T, editors. Pathogenesis and therapy of amyotrophic lateral sclerosis. Adv Neurol 1995; 68: 163–184.
4. Brooks BR, Sufit RL, DePaul R, Tan YD, Sanjak M, Robbins J. Design of clinical therapeutic trials in amyotrophic lateral sclerosis. In: Rowland LP, editor. Amyotrophic lateral sclerosis and other motor neuron diseases. Adv Neurol 1991; 56: 521–546.
5. Brooks BR. Emerging directions in ALS therapeutics — palliative therapies at the advent of the twenty-first century. Clin Neurosci 1996; 3: 386–392.